Cargando…

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma

We examined the efficacy of selective inhibition of cyclin-dependent kinase 5 (CDK5) in glioblastoma by TP5. We analyzed its impact in vitro on CDK5 expression and activity, cell survival, apoptosis and cell cycle. DNA damage was analyzed using the expression of γH2A.X and phosphorylated ATM. Its to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabouret, Emeline, Wang, Herui, Amin, Niranjana, Jung, Jinkyu, Appay, Romain, Cui, Jing, Song, Qi, Cardone, Antonio, Park, Deric M., Gilbert, Mark R., Pant, Harish, Zhuang, Zhengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409269/ https://www.ncbi.nlm.nih.gov/pubmed/32708903 http://dx.doi.org/10.3390/cancers12071935

Ejemplares similares

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma
por: Amin, Niranjana, et al.
Publicado: (2023)

Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in in vitro and in vivo models of Parkinson’s disease
por: Tran, Judith, et al.
Publicado: (2021)

Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease
por: Binukumar, BK., et al.
Publicado: (2015)

TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease
por: Binukumar, BK, et al.
Publicado: (2016)

Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein
por: Binukumar, B.K., et al.
Publicado: (2015)

Cdk5 Inhibitory Peptide (CIP) Inhibits Cdk5/p25 Activity Induced by High Glucose in Pancreatic Beta Cells and Recovers Insulin Secretion from p25 Damage
por: Zheng, Ya-Li, et al.
Publicado: (2013)

Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status
por: Eyraud, Rémi, et al.
Publicado: (2023)

Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(−/−) Mice
por: Contreras-Vallejos, Erick, et al.
Publicado: (2014)

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
por: Demelash, Abeba, et al.
Publicado: (2012)

Cdk5 and aberrant cell cycle activation at the core of neurodegeneration
por: Requejo-Aguilar, Raquel
Publicado: (2022)

The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35
por: Amin, Niranjana D., et al.
Publicado: (2016)

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
por: Zheng, Ya-Li, et al.
Publicado: (2016)

Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
por: Crews, L, et al.
Publicado: (2011)

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2019)

Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
por: Shukla, Arvind Kumar, et al.
Publicado: (2019)

Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
por: Shukla, Arvind Kumar, et al.
Publicado: (2021)

Targeting CDK9 for the Treatment of Glioblastoma
por: Ranjan, Alice, et al.
Publicado: (2021)

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
por: Jiguet-Jiglaire, Carine, et al.
Publicado: (2022)

Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation
por: Peyressatre, Marion, et al.
Publicado: (2020)

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
por: Appay, Romain, et al.
Publicado: (2018)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
por: Prochazkova, Michaela, et al.
Publicado: (2013)

Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool
por: Tsvetkov, Philipp O., et al.
Publicado: (2018)

CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma
por: Zhou, Yan, et al.
Publicado: (2021)

Premature Cdk1/Cdc5/Mus81 pathway activation induces aberrant replication and deleterious crossover
por: Szakal, Barnabas, et al.
Publicado: (2013)

Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma
por: Lookian, Pashayar P., et al.
Publicado: (2021)

Deciphering the Action of Neuraminidase in Glioblastoma Models
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2023)

Cdk5 protects huntingtin
por: LeBrasseur, Nicole
Publicado: (2005)

Three decades of Cdk5
por: Pao, Ping-Chieh, et al.
Publicado: (2021)

The CDK5 repressor CDK5RAP1 is a methylthiotransferase acting on nuclear and mitochondrial RNA
por: Reiter, Veronika, et al.
Publicado: (2012)

Molecular heterogeneity of glioblastomas: does location matter?
por: Denicolaï, Emilie, et al.
Publicado: (2015)

Cdk5 deficiency and neurodegeneration in flies
Publicado: (2012)

The role of Cdk5 in neurological disorders
por: Ao, Chuncao, et al.
Publicado: (2022)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes
por: Pao, Ping-Chieh, et al.
Publicado: (2023)

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons
por: Veas-Pérez de Tudela, Miguel, et al.
Publicado: (2015)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke
por: Tuo, Qing-Zhang, et al.
Publicado: (2018)

DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells
por: Chen, Brianna, et al.
Publicado: (2021)

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo
por: Berges, Raphael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jdogs7ff49ev9bncbscmvapit5